DRUG DELIVERY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2135124, encodeId=6093213512468, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：3月中旬投稿一直没有消息发邮件催了两次五月初被拒两个审稿人都很友好但编辑觉得研究的比较浅显没有体内实验拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbcf8552628, createdName=ms6000002070142828, createdTime=Tue May 16 14:50:51 CST 2023, time=2023-05-16, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=856686, encodeId=fb6e85668659, content=1月3号投的，现在1月10号还是with journal administrator，大家这个阶段是多久啊？着急毕业！好慌！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84af5414040, createdName=ms1437042654898988, createdTime=Fri Jan 10 08:20:43 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096575, encodeId=830120965e595, content=偏重的研究方向：肿瘤靶向;材料;药物传递系统 经验分享：已经out for review 快20天了，中间日期变了一下，大家外审一般多久。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2a58129051, createdName=ms9000001005193010, createdTime=Thu Oct 27 23:15:09 CST 2022, time=2022-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207203, encodeId=89a5120e203bd, content=想请问一下，这个期刊的with editor 后的decision depending 是已经外审了，还是说要被拒了，已经大概7天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/y2fSgcKaBzLM508DA6SyUHjaTj0VpGmiaKPgTVicfCLQIZ1wcibv1so902LzPWusCYEYhedf5tGxfNkA4BDgO4eMQ/132, createdBy=210a5264764, createdName=肥勤, createdTime=Wed Mar 30 14:19:54 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854966, encodeId=bbf385496616, content=审稿速度:1.0 经验分享：投稿是11月9号投的，到现在已经是整整5天了，状态由最开始的with journal administrator ，变成了editor's decision in process，请问这是什么意思呢，是编辑决定不送审了，要拒了，还是应该有的一个步骤呢，着急， , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=069a5414125, createdName=ms6134842258072312, createdTime=Thu Nov 14 13:17:34 CST 2019, time=2019-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089794, encodeId=301a1089e94d4, content=如何判断SCI文章类型？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089793, encodeId=a6a91089e938f, content=我们做研究时最常见或撰写的SCI文章类型是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566216, encodeId=3ba6566216fe, content=已经接受2篇文章了，不得不说，审稿效率非常高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f0c84034, createdName=whiteblue, createdTime=Sun Jan 27 10:30:00 CST 2019, time=2019-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=894229, encodeId=926289422920, content=请问怎么投稿，有投过的同僚给分享一下投稿经验吗？可以联系一下我吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=95a45428576, createdName=ms6000001409185126, createdTime=Sun Oct 25 01:58:51 CST 2020, time=2020-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586737, encodeId=57e2586e3751, content=自引这么高会被踢吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cd2b5180633, createdName=146f6ef6m90(暂无昵称), createdTime=Mon Mar 16 00:00:00 CST 2020, time=2020-03-16, status=1, ipAttribution=)]

2023-05-16 ms6000002070142828 来自安徽省

审稿速度:2.0 | 投稿命中率:50.0
经验分享：3月中旬投稿一直没有消息发邮件催了两次五月初被拒两个审稿人都很友好但编辑觉得研究的比较浅显没有体内实验拒稿

0 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=2135124, encodeId=6093213512468, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：3月中旬投稿一直没有消息发邮件催了两次五月初被拒两个审稿人都很友好但编辑觉得研究的比较浅显没有体内实验拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbcf8552628, createdName=ms6000002070142828, createdTime=Tue May 16 14:50:51 CST 2023, time=2023-05-16, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=856686, encodeId=fb6e85668659, content=1月3号投的，现在1月10号还是with journal administrator，大家这个阶段是多久啊？着急毕业！好慌！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84af5414040, createdName=ms1437042654898988, createdTime=Fri Jan 10 08:20:43 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096575, encodeId=830120965e595, content=偏重的研究方向：肿瘤靶向;材料;药物传递系统 经验分享：已经out for review 快20天了，中间日期变了一下，大家外审一般多久。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2a58129051, createdName=ms9000001005193010, createdTime=Thu Oct 27 23:15:09 CST 2022, time=2022-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207203, encodeId=89a5120e203bd, content=想请问一下，这个期刊的with editor 后的decision depending 是已经外审了，还是说要被拒了，已经大概7天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/y2fSgcKaBzLM508DA6SyUHjaTj0VpGmiaKPgTVicfCLQIZ1wcibv1so902LzPWusCYEYhedf5tGxfNkA4BDgO4eMQ/132, createdBy=210a5264764, createdName=肥勤, createdTime=Wed Mar 30 14:19:54 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854966, encodeId=bbf385496616, content=审稿速度:1.0 经验分享：投稿是11月9号投的，到现在已经是整整5天了，状态由最开始的with journal administrator ，变成了editor's decision in process，请问这是什么意思呢，是编辑决定不送审了，要拒了，还是应该有的一个步骤呢，着急， , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=069a5414125, createdName=ms6134842258072312, createdTime=Thu Nov 14 13:17:34 CST 2019, time=2019-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089794, encodeId=301a1089e94d4, content=如何判断SCI文章类型？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089793, encodeId=a6a91089e938f, content=我们做研究时最常见或撰写的SCI文章类型是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566216, encodeId=3ba6566216fe, content=已经接受2篇文章了，不得不说，审稿效率非常高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f0c84034, createdName=whiteblue, createdTime=Sun Jan 27 10:30:00 CST 2019, time=2019-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=894229, encodeId=926289422920, content=请问怎么投稿，有投过的同僚给分享一下投稿经验吗？可以联系一下我吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=95a45428576, createdName=ms6000001409185126, createdTime=Sun Oct 25 01:58:51 CST 2020, time=2020-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586737, encodeId=57e2586e3751, content=自引这么高会被踢吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cd2b5180633, createdName=146f6ef6m90(暂无昵称), createdTime=Mon Mar 16 00:00:00 CST 2020, time=2020-03-16, status=1, ipAttribution=)]

2020-01-10 ms1437042654898988

1月3号投的，现在1月10号还是with journal administrator，大家这个阶段是多久啊？着急毕业！好慌！

147 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2135124, encodeId=6093213512468, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：3月中旬投稿一直没有消息发邮件催了两次五月初被拒两个审稿人都很友好但编辑觉得研究的比较浅显没有体内实验拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbcf8552628, createdName=ms6000002070142828, createdTime=Tue May 16 14:50:51 CST 2023, time=2023-05-16, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=856686, encodeId=fb6e85668659, content=1月3号投的，现在1月10号还是with journal administrator，大家这个阶段是多久啊？着急毕业！好慌！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84af5414040, createdName=ms1437042654898988, createdTime=Fri Jan 10 08:20:43 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096575, encodeId=830120965e595, content=偏重的研究方向：肿瘤靶向;材料;药物传递系统 经验分享：已经out for review 快20天了，中间日期变了一下，大家外审一般多久。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2a58129051, createdName=ms9000001005193010, createdTime=Thu Oct 27 23:15:09 CST 2022, time=2022-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207203, encodeId=89a5120e203bd, content=想请问一下，这个期刊的with editor 后的decision depending 是已经外审了，还是说要被拒了，已经大概7天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/y2fSgcKaBzLM508DA6SyUHjaTj0VpGmiaKPgTVicfCLQIZ1wcibv1so902LzPWusCYEYhedf5tGxfNkA4BDgO4eMQ/132, createdBy=210a5264764, createdName=肥勤, createdTime=Wed Mar 30 14:19:54 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854966, encodeId=bbf385496616, content=审稿速度:1.0 经验分享：投稿是11月9号投的，到现在已经是整整5天了，状态由最开始的with journal administrator ，变成了editor's decision in process，请问这是什么意思呢，是编辑决定不送审了，要拒了，还是应该有的一个步骤呢，着急， , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=069a5414125, createdName=ms6134842258072312, createdTime=Thu Nov 14 13:17:34 CST 2019, time=2019-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089794, encodeId=301a1089e94d4, content=如何判断SCI文章类型？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089793, encodeId=a6a91089e938f, content=我们做研究时最常见或撰写的SCI文章类型是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566216, encodeId=3ba6566216fe, content=已经接受2篇文章了，不得不说，审稿效率非常高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f0c84034, createdName=whiteblue, createdTime=Sun Jan 27 10:30:00 CST 2019, time=2019-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=894229, encodeId=926289422920, content=请问怎么投稿，有投过的同僚给分享一下投稿经验吗？可以联系一下我吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=95a45428576, createdName=ms6000001409185126, createdTime=Sun Oct 25 01:58:51 CST 2020, time=2020-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586737, encodeId=57e2586e3751, content=自引这么高会被踢吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cd2b5180633, createdName=146f6ef6m90(暂无昵称), createdTime=Mon Mar 16 00:00:00 CST 2020, time=2020-03-16, status=1, ipAttribution=)]

2022-10-27 ms9000001005193010

偏重的研究方向：肿瘤靶向;材料;药物传递系统
经验分享：已经out for review 快20天了，中间日期变了一下，大家外审一般多久。

34 0

[GetPortalCommentsPageByObjectIdResponse(id=2135124, encodeId=6093213512468, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：3月中旬投稿一直没有消息发邮件催了两次五月初被拒两个审稿人都很友好但编辑觉得研究的比较浅显没有体内实验拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbcf8552628, createdName=ms6000002070142828, createdTime=Tue May 16 14:50:51 CST 2023, time=2023-05-16, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=856686, encodeId=fb6e85668659, content=1月3号投的，现在1月10号还是with journal administrator，大家这个阶段是多久啊？着急毕业！好慌！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84af5414040, createdName=ms1437042654898988, createdTime=Fri Jan 10 08:20:43 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096575, encodeId=830120965e595, content=偏重的研究方向：肿瘤靶向;材料;药物传递系统 经验分享：已经out for review 快20天了，中间日期变了一下，大家外审一般多久。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2a58129051, createdName=ms9000001005193010, createdTime=Thu Oct 27 23:15:09 CST 2022, time=2022-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207203, encodeId=89a5120e203bd, content=想请问一下，这个期刊的with editor 后的decision depending 是已经外审了，还是说要被拒了，已经大概7天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/y2fSgcKaBzLM508DA6SyUHjaTj0VpGmiaKPgTVicfCLQIZ1wcibv1so902LzPWusCYEYhedf5tGxfNkA4BDgO4eMQ/132, createdBy=210a5264764, createdName=肥勤, createdTime=Wed Mar 30 14:19:54 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854966, encodeId=bbf385496616, content=审稿速度:1.0 经验分享：投稿是11月9号投的，到现在已经是整整5天了，状态由最开始的with journal administrator ，变成了editor's decision in process，请问这是什么意思呢，是编辑决定不送审了，要拒了，还是应该有的一个步骤呢，着急， , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=069a5414125, createdName=ms6134842258072312, createdTime=Thu Nov 14 13:17:34 CST 2019, time=2019-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089794, encodeId=301a1089e94d4, content=如何判断SCI文章类型？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089793, encodeId=a6a91089e938f, content=我们做研究时最常见或撰写的SCI文章类型是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566216, encodeId=3ba6566216fe, content=已经接受2篇文章了，不得不说，审稿效率非常高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f0c84034, createdName=whiteblue, createdTime=Sun Jan 27 10:30:00 CST 2019, time=2019-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=894229, encodeId=926289422920, content=请问怎么投稿，有投过的同僚给分享一下投稿经验吗？可以联系一下我吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=95a45428576, createdName=ms6000001409185126, createdTime=Sun Oct 25 01:58:51 CST 2020, time=2020-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586737, encodeId=57e2586e3751, content=自引这么高会被踢吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cd2b5180633, createdName=146f6ef6m90(暂无昵称), createdTime=Mon Mar 16 00:00:00 CST 2020, time=2020-03-16, status=1, ipAttribution=)]

2022-03-30 肥勤

想请问一下，这个期刊的with editor 后的decision depending 是已经外审了，还是说要被拒了，已经大概7天了

55 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=2135124, encodeId=6093213512468, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：3月中旬投稿一直没有消息发邮件催了两次五月初被拒两个审稿人都很友好但编辑觉得研究的比较浅显没有体内实验拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbcf8552628, createdName=ms6000002070142828, createdTime=Tue May 16 14:50:51 CST 2023, time=2023-05-16, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=856686, encodeId=fb6e85668659, content=1月3号投的，现在1月10号还是with journal administrator，大家这个阶段是多久啊？着急毕业！好慌！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84af5414040, createdName=ms1437042654898988, createdTime=Fri Jan 10 08:20:43 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096575, encodeId=830120965e595, content=偏重的研究方向：肿瘤靶向;材料;药物传递系统 经验分享：已经out for review 快20天了，中间日期变了一下，大家外审一般多久。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2a58129051, createdName=ms9000001005193010, createdTime=Thu Oct 27 23:15:09 CST 2022, time=2022-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207203, encodeId=89a5120e203bd, content=想请问一下，这个期刊的with editor 后的decision depending 是已经外审了，还是说要被拒了，已经大概7天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/y2fSgcKaBzLM508DA6SyUHjaTj0VpGmiaKPgTVicfCLQIZ1wcibv1so902LzPWusCYEYhedf5tGxfNkA4BDgO4eMQ/132, createdBy=210a5264764, createdName=肥勤, createdTime=Wed Mar 30 14:19:54 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854966, encodeId=bbf385496616, content=审稿速度:1.0 经验分享：投稿是11月9号投的，到现在已经是整整5天了，状态由最开始的with journal administrator ，变成了editor's decision in process，请问这是什么意思呢，是编辑决定不送审了，要拒了，还是应该有的一个步骤呢，着急， , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=069a5414125, createdName=ms6134842258072312, createdTime=Thu Nov 14 13:17:34 CST 2019, time=2019-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089794, encodeId=301a1089e94d4, content=如何判断SCI文章类型？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089793, encodeId=a6a91089e938f, content=我们做研究时最常见或撰写的SCI文章类型是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566216, encodeId=3ba6566216fe, content=已经接受2篇文章了，不得不说，审稿效率非常高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f0c84034, createdName=whiteblue, createdTime=Sun Jan 27 10:30:00 CST 2019, time=2019-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=894229, encodeId=926289422920, content=请问怎么投稿，有投过的同僚给分享一下投稿经验吗？可以联系一下我吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=95a45428576, createdName=ms6000001409185126, createdTime=Sun Oct 25 01:58:51 CST 2020, time=2020-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586737, encodeId=57e2586e3751, content=自引这么高会被踢吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cd2b5180633, createdName=146f6ef6m90(暂无昵称), createdTime=Mon Mar 16 00:00:00 CST 2020, time=2020-03-16, status=1, ipAttribution=)]

2019-11-14 ms6134842258072312

审稿速度:1.0
经验分享：投稿是11月9号投的，到现在已经是整整5天了，状态由最开始的with journal administrator ，变成了editor's decision in process，请问这是什么意思呢，是编辑决定不送审了，要拒了，还是应该有的一个步骤呢，着急，

154 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2135124, encodeId=6093213512468, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：3月中旬投稿一直没有消息发邮件催了两次五月初被拒两个审稿人都很友好但编辑觉得研究的比较浅显没有体内实验拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbcf8552628, createdName=ms6000002070142828, createdTime=Tue May 16 14:50:51 CST 2023, time=2023-05-16, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=856686, encodeId=fb6e85668659, content=1月3号投的，现在1月10号还是with journal administrator，大家这个阶段是多久啊？着急毕业！好慌！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84af5414040, createdName=ms1437042654898988, createdTime=Fri Jan 10 08:20:43 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096575, encodeId=830120965e595, content=偏重的研究方向：肿瘤靶向;材料;药物传递系统 经验分享：已经out for review 快20天了，中间日期变了一下，大家外审一般多久。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2a58129051, createdName=ms9000001005193010, createdTime=Thu Oct 27 23:15:09 CST 2022, time=2022-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207203, encodeId=89a5120e203bd, content=想请问一下，这个期刊的with editor 后的decision depending 是已经外审了，还是说要被拒了，已经大概7天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/y2fSgcKaBzLM508DA6SyUHjaTj0VpGmiaKPgTVicfCLQIZ1wcibv1so902LzPWusCYEYhedf5tGxfNkA4BDgO4eMQ/132, createdBy=210a5264764, createdName=肥勤, createdTime=Wed Mar 30 14:19:54 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854966, encodeId=bbf385496616, content=审稿速度:1.0 经验分享：投稿是11月9号投的，到现在已经是整整5天了，状态由最开始的with journal administrator ，变成了editor's decision in process，请问这是什么意思呢，是编辑决定不送审了，要拒了，还是应该有的一个步骤呢，着急， , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=069a5414125, createdName=ms6134842258072312, createdTime=Thu Nov 14 13:17:34 CST 2019, time=2019-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089794, encodeId=301a1089e94d4, content=如何判断SCI文章类型？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089793, encodeId=a6a91089e938f, content=我们做研究时最常见或撰写的SCI文章类型是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566216, encodeId=3ba6566216fe, content=已经接受2篇文章了，不得不说，审稿效率非常高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f0c84034, createdName=whiteblue, createdTime=Sun Jan 27 10:30:00 CST 2019, time=2019-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=894229, encodeId=926289422920, content=请问怎么投稿，有投过的同僚给分享一下投稿经验吗？可以联系一下我吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=95a45428576, createdName=ms6000001409185126, createdTime=Sun Oct 25 01:58:51 CST 2020, time=2020-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586737, encodeId=57e2586e3751, content=自引这么高会被踢吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cd2b5180633, createdName=146f6ef6m90(暂无昵称), createdTime=Mon Mar 16 00:00:00 CST 2020, time=2020-03-16, status=1, ipAttribution=)]

2021-12-28 msSSSSSD

如何判断SCI文章类型？

51 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2135124, encodeId=6093213512468, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：3月中旬投稿一直没有消息发邮件催了两次五月初被拒两个审稿人都很友好但编辑觉得研究的比较浅显没有体内实验拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbcf8552628, createdName=ms6000002070142828, createdTime=Tue May 16 14:50:51 CST 2023, time=2023-05-16, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=856686, encodeId=fb6e85668659, content=1月3号投的，现在1月10号还是with journal administrator，大家这个阶段是多久啊？着急毕业！好慌！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84af5414040, createdName=ms1437042654898988, createdTime=Fri Jan 10 08:20:43 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096575, encodeId=830120965e595, content=偏重的研究方向：肿瘤靶向;材料;药物传递系统 经验分享：已经out for review 快20天了，中间日期变了一下，大家外审一般多久。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2a58129051, createdName=ms9000001005193010, createdTime=Thu Oct 27 23:15:09 CST 2022, time=2022-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207203, encodeId=89a5120e203bd, content=想请问一下，这个期刊的with editor 后的decision depending 是已经外审了，还是说要被拒了，已经大概7天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/y2fSgcKaBzLM508DA6SyUHjaTj0VpGmiaKPgTVicfCLQIZ1wcibv1so902LzPWusCYEYhedf5tGxfNkA4BDgO4eMQ/132, createdBy=210a5264764, createdName=肥勤, createdTime=Wed Mar 30 14:19:54 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854966, encodeId=bbf385496616, content=审稿速度:1.0 经验分享：投稿是11月9号投的，到现在已经是整整5天了，状态由最开始的with journal administrator ，变成了editor's decision in process，请问这是什么意思呢，是编辑决定不送审了，要拒了，还是应该有的一个步骤呢，着急， , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=069a5414125, createdName=ms6134842258072312, createdTime=Thu Nov 14 13:17:34 CST 2019, time=2019-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089794, encodeId=301a1089e94d4, content=如何判断SCI文章类型？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089793, encodeId=a6a91089e938f, content=我们做研究时最常见或撰写的SCI文章类型是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566216, encodeId=3ba6566216fe, content=已经接受2篇文章了，不得不说，审稿效率非常高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f0c84034, createdName=whiteblue, createdTime=Sun Jan 27 10:30:00 CST 2019, time=2019-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=894229, encodeId=926289422920, content=请问怎么投稿，有投过的同僚给分享一下投稿经验吗？可以联系一下我吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=95a45428576, createdName=ms6000001409185126, createdTime=Sun Oct 25 01:58:51 CST 2020, time=2020-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586737, encodeId=57e2586e3751, content=自引这么高会被踢吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cd2b5180633, createdName=146f6ef6m90(暂无昵称), createdTime=Mon Mar 16 00:00:00 CST 2020, time=2020-03-16, status=1, ipAttribution=)]

2021-12-27 ms6000000264964247

我们做研究时最常见或撰写的SCI文章类型是什么？

51 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2135124, encodeId=6093213512468, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：3月中旬投稿一直没有消息发邮件催了两次五月初被拒两个审稿人都很友好但编辑觉得研究的比较浅显没有体内实验拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbcf8552628, createdName=ms6000002070142828, createdTime=Tue May 16 14:50:51 CST 2023, time=2023-05-16, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=856686, encodeId=fb6e85668659, content=1月3号投的，现在1月10号还是with journal administrator，大家这个阶段是多久啊？着急毕业！好慌！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84af5414040, createdName=ms1437042654898988, createdTime=Fri Jan 10 08:20:43 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096575, encodeId=830120965e595, content=偏重的研究方向：肿瘤靶向;材料;药物传递系统 经验分享：已经out for review 快20天了，中间日期变了一下，大家外审一般多久。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2a58129051, createdName=ms9000001005193010, createdTime=Thu Oct 27 23:15:09 CST 2022, time=2022-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207203, encodeId=89a5120e203bd, content=想请问一下，这个期刊的with editor 后的decision depending 是已经外审了，还是说要被拒了，已经大概7天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/y2fSgcKaBzLM508DA6SyUHjaTj0VpGmiaKPgTVicfCLQIZ1wcibv1so902LzPWusCYEYhedf5tGxfNkA4BDgO4eMQ/132, createdBy=210a5264764, createdName=肥勤, createdTime=Wed Mar 30 14:19:54 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854966, encodeId=bbf385496616, content=审稿速度:1.0 经验分享：投稿是11月9号投的，到现在已经是整整5天了，状态由最开始的with journal administrator ，变成了editor's decision in process，请问这是什么意思呢，是编辑决定不送审了，要拒了，还是应该有的一个步骤呢，着急， , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=069a5414125, createdName=ms6134842258072312, createdTime=Thu Nov 14 13:17:34 CST 2019, time=2019-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089794, encodeId=301a1089e94d4, content=如何判断SCI文章类型？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089793, encodeId=a6a91089e938f, content=我们做研究时最常见或撰写的SCI文章类型是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566216, encodeId=3ba6566216fe, content=已经接受2篇文章了，不得不说，审稿效率非常高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f0c84034, createdName=whiteblue, createdTime=Sun Jan 27 10:30:00 CST 2019, time=2019-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=894229, encodeId=926289422920, content=请问怎么投稿，有投过的同僚给分享一下投稿经验吗？可以联系一下我吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=95a45428576, createdName=ms6000001409185126, createdTime=Sun Oct 25 01:58:51 CST 2020, time=2020-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586737, encodeId=57e2586e3751, content=自引这么高会被踢吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cd2b5180633, createdName=146f6ef6m90(暂无昵称), createdTime=Mon Mar 16 00:00:00 CST 2020, time=2020-03-16, status=1, ipAttribution=)]

2019-01-27 whiteblue

已经接受2篇文章了，不得不说，审稿效率非常高。

212 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2135124, encodeId=6093213512468, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：3月中旬投稿一直没有消息发邮件催了两次五月初被拒两个审稿人都很友好但编辑觉得研究的比较浅显没有体内实验拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbcf8552628, createdName=ms6000002070142828, createdTime=Tue May 16 14:50:51 CST 2023, time=2023-05-16, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=856686, encodeId=fb6e85668659, content=1月3号投的，现在1月10号还是with journal administrator，大家这个阶段是多久啊？着急毕业！好慌！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84af5414040, createdName=ms1437042654898988, createdTime=Fri Jan 10 08:20:43 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096575, encodeId=830120965e595, content=偏重的研究方向：肿瘤靶向;材料;药物传递系统 经验分享：已经out for review 快20天了，中间日期变了一下，大家外审一般多久。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2a58129051, createdName=ms9000001005193010, createdTime=Thu Oct 27 23:15:09 CST 2022, time=2022-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207203, encodeId=89a5120e203bd, content=想请问一下，这个期刊的with editor 后的decision depending 是已经外审了，还是说要被拒了，已经大概7天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/y2fSgcKaBzLM508DA6SyUHjaTj0VpGmiaKPgTVicfCLQIZ1wcibv1so902LzPWusCYEYhedf5tGxfNkA4BDgO4eMQ/132, createdBy=210a5264764, createdName=肥勤, createdTime=Wed Mar 30 14:19:54 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854966, encodeId=bbf385496616, content=审稿速度:1.0 经验分享：投稿是11月9号投的，到现在已经是整整5天了，状态由最开始的with journal administrator ，变成了editor's decision in process，请问这是什么意思呢，是编辑决定不送审了，要拒了，还是应该有的一个步骤呢，着急， , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=069a5414125, createdName=ms6134842258072312, createdTime=Thu Nov 14 13:17:34 CST 2019, time=2019-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089794, encodeId=301a1089e94d4, content=如何判断SCI文章类型？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089793, encodeId=a6a91089e938f, content=我们做研究时最常见或撰写的SCI文章类型是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566216, encodeId=3ba6566216fe, content=已经接受2篇文章了，不得不说，审稿效率非常高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f0c84034, createdName=whiteblue, createdTime=Sun Jan 27 10:30:00 CST 2019, time=2019-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=894229, encodeId=926289422920, content=请问怎么投稿，有投过的同僚给分享一下投稿经验吗？可以联系一下我吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=95a45428576, createdName=ms6000001409185126, createdTime=Sun Oct 25 01:58:51 CST 2020, time=2020-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586737, encodeId=57e2586e3751, content=自引这么高会被踢吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cd2b5180633, createdName=146f6ef6m90(暂无昵称), createdTime=Mon Mar 16 00:00:00 CST 2020, time=2020-03-16, status=1, ipAttribution=)]

2020-10-25 ms6000001409185126

请问怎么投稿，有投过的同僚给分享一下投稿经验吗？可以联系一下我吗？

1 0

[GetPortalCommentsPageByObjectIdResponse(id=2135124, encodeId=6093213512468, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：3月中旬投稿一直没有消息发邮件催了两次五月初被拒两个审稿人都很友好但编辑觉得研究的比较浅显没有体内实验拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbcf8552628, createdName=ms6000002070142828, createdTime=Tue May 16 14:50:51 CST 2023, time=2023-05-16, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=856686, encodeId=fb6e85668659, content=1月3号投的，现在1月10号还是with journal administrator，大家这个阶段是多久啊？着急毕业！好慌！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84af5414040, createdName=ms1437042654898988, createdTime=Fri Jan 10 08:20:43 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096575, encodeId=830120965e595, content=偏重的研究方向：肿瘤靶向;材料;药物传递系统 经验分享：已经out for review 快20天了，中间日期变了一下，大家外审一般多久。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2a58129051, createdName=ms9000001005193010, createdTime=Thu Oct 27 23:15:09 CST 2022, time=2022-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207203, encodeId=89a5120e203bd, content=想请问一下，这个期刊的with editor 后的decision depending 是已经外审了，还是说要被拒了，已经大概7天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/y2fSgcKaBzLM508DA6SyUHjaTj0VpGmiaKPgTVicfCLQIZ1wcibv1so902LzPWusCYEYhedf5tGxfNkA4BDgO4eMQ/132, createdBy=210a5264764, createdName=肥勤, createdTime=Wed Mar 30 14:19:54 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854966, encodeId=bbf385496616, content=审稿速度:1.0 经验分享：投稿是11月9号投的，到现在已经是整整5天了，状态由最开始的with journal administrator ，变成了editor's decision in process，请问这是什么意思呢，是编辑决定不送审了，要拒了，还是应该有的一个步骤呢，着急， , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=069a5414125, createdName=ms6134842258072312, createdTime=Thu Nov 14 13:17:34 CST 2019, time=2019-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089794, encodeId=301a1089e94d4, content=如何判断SCI文章类型？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089793, encodeId=a6a91089e938f, content=我们做研究时最常见或撰写的SCI文章类型是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566216, encodeId=3ba6566216fe, content=已经接受2篇文章了，不得不说，审稿效率非常高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f0c84034, createdName=whiteblue, createdTime=Sun Jan 27 10:30:00 CST 2019, time=2019-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=894229, encodeId=926289422920, content=请问怎么投稿，有投过的同僚给分享一下投稿经验吗？可以联系一下我吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=95a45428576, createdName=ms6000001409185126, createdTime=Sun Oct 25 01:58:51 CST 2020, time=2020-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586737, encodeId=57e2586e3751, content=自引这么高会被踢吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cd2b5180633, createdName=146f6ef6m90(暂无昵称), createdTime=Mon Mar 16 00:00:00 CST 2020, time=2020-03-16, status=1, ipAttribution=)]

2020-03-16 146f6ef6m90(暂无昵称)

自引这么高会被踢吗

149 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务